#CRISPR

Researchers found a new gene, ZFP36L1, that hasn’t been studied in association with small-cell lung cancer and the protein LSD1.

Researchers better understand how a SHOC2 protein structure plays a part in mutations in RAS genes, which often drive tumor growth.

Watch groundbreaking scientists share their experiences and explain how Damon Runyon funding makes a difference in cancer research.

Damon Runyon Cancer Research Foundation Fellows are mapping the genetics of DNA repair, with implications for cancer research.

Researchers looking at ovarian cancer cells that resist chemotherapy hope to develop new therapeutic strategies.

The gene-editing tool can alter the DNA of human cells like a precise pair of scissors.

Edited T cells survive and thrive in three patients in the first U.S. trial using this approach.

In mouse study, gene-edited cells stay safe as immunotherapy attacks cancer

This mix-up may help explain why cancer drugs aren’t always as effective as hoped.

Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.

The new method may increase gene editing efficiency and safety for future use in human cells.

The technique prevents transplant rejection in the lab, a major advance for stem cell therapies.

Scientists are preparing to bring DNA-editing tools to the clinic.

The researchers hope to soon increase the scale of their gene mapping to focus on diseases such as lung cancer and prostate cancer.

Innovative CRISPR study recreates genetic steps required for benign moles to turn malignant

Scientists have discovered a swifter and more precise way to edit the genome of immune cells, opening doors for cancer and HIV therapies.